Gilead holds 25.54% of Galapagos shares
11 Gennaio 2021 - 10:01PM
Mechelen, Belgium; 11 January 2021; 22.01 CET; regulated
information – Galapagos NV (Euronext & NASDAQ: GLPG) received a
transparency notification from Gilead Sciences, Inc.
Pursuant to Belgian transparency legislation1, Galapagos
received a transparency notification on 6 January 2021 from Gilead
Sciences, Inc., who notified a change in the chain of intermediary
companies through which Gilead holds its shares in Galapagos. The
change in the chain of intermediary companies is the result of an
internal reorganization as a result of which Gilead holds its
shares in Galapagos as of 31 December 2020 through its direct
subsidiary Gilead Biopharmaceutics US, LLC, which through Gilead
Sciences Ireland UC controls Gilead Therapeutics A1 Unlimited
Company, which in turn holds 16,707,477 of Galapagos' voting
rights, consisting of 16,707,477 shares (unchanged). Those
16,707,477 shares represent 25.54% of Galapagos' currently
outstanding 65,411,767 shares.
The full transparency notification is available
on the Galapagos website.
About GalapagosGalapagos NV
discovers and develops small molecule medicines with novel modes of
action, several of which show promising patient results and are
currently in late-stage development in multiple diseases. Our
pipeline comprises Phase 3 through to discovery programs in
inflammation, fibrosis, and other indications. Our ambition is to
become a leading global biopharmaceutical company focused on the
discovery, development and commercialization of innovative
medicines. More information at www.glpg.com.
Contacts
Investors:
Elizabeth Goodwin VP Investor Relations +1 781 460 1784
Sofie Van Gijsel Senior Director Investor Relations +32 485 19
14 15 ir@glpg.com
Media: Carmen Vroonen Global Head
Communications & Public Affairs +32 473 824 874
Anna GibbinsSenior Director Therapeutic Areas Communications+44
7717 801900communications@glpg.com
1 Belgian Act of 2 May 2007 on the disclosure of major
shareholdings in issuers whose shares are admitted to trading on a
regulated market and regarding miscellaneous provisions, as amended
from time to time.
- Gilead holds 25.54% of Galapagos shares
Grafico Azioni Galapagos (EU:GLPG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Galapagos (EU:GLPG)
Storico
Da Apr 2023 a Apr 2024